Dr Michael Tse-yin Lu, MD - Medicare Diagnostic Radiology in Boston, MA

Dr Michael Tse-yin Lu, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Boston, Massachusetts. He went to Harvard Medical School and graduated in 2007 and has 17 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Massachusetts General Physicians Organization Inc, Massachusetts General Physicians Organization Inc and his current practice location is 55 Fruit St, Massachusetts General Hospital, Department Of Radiology, Boston, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (161) 724-9729.

Dr Michael Tse-yin Lu is licensed to practice in Massachusetts (license number 250734) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013242098.

Contact Information

Dr Michael Tse-yin Lu, MD
55 Fruit St, Massachusetts General Hospital, Department Of Radiology,
Boston, MA 02114-2621
(161) 724-9729
Not Available



Physician's Profile

Full NameDr Michael Tse-yin Lu
GenderMale
SpecialityDiagnostic Radiology
Experience17 Years
Location55 Fruit St, Boston, Massachusetts
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Michael Tse-yin Lu attended and graduated from Harvard Medical School in 2007
  NPI Data:
  • NPI Number: 1013242098
  • Provider Enumeration Date: 10/08/2009
  • Last Update Date: 06/28/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 2668638867
  • Enrollment ID: I20120716000200

Medical Identifiers

Medical identifiers for Dr Michael Tse-yin Lu such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013242098NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology A 107408 (California)Secondary
2085R0202XRadiology - Diagnostic Radiology 250734 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Massachusetts General HospitalBoston, MAHospital
Newton-wellesley HospitalNewton, MAHospital
North Shore Medical Center -Salem, MAHospital
Wentworth-douglass HospitalDover, NHHospital
Martha's Vineyard Hospital IncOak bluffs, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Massachusetts General Physicians Organization Inc24663658203085
Massachusetts General Physicians Organization Inc24663658203085

News Archive

CDI, Promega enter collaboration for toxicity testing in drug discovery process

Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.

Researchers demonstrate important functional role of lincRNA in immune system

A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Interview highlights Kenya's first national health conference, examines role of women in building strong health systems

In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."

Students will temporarily lose their sight in an attempt to gain an understanding of what it could be like to have vision impairment

"Students are blindfolded for a period of about one hour," she said. "It really demonstrates how much we take for granted – suddenly activities such as eating and socialising become difficult and exhausting. There is always at least one dinner guest who feels they can't cope and has to remove their blindfold."

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Michael Tse-yin Lu allows following entities to bill medicare on his behalf.
Entity NameMassachusetts General Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801874573
PECOS PAC ID: 2466365820
Enrollment ID: O20031111000434

News Archive

CDI, Promega enter collaboration for toxicity testing in drug discovery process

Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.

Researchers demonstrate important functional role of lincRNA in immune system

A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Interview highlights Kenya's first national health conference, examines role of women in building strong health systems

In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."

Students will temporarily lose their sight in an attempt to gain an understanding of what it could be like to have vision impairment

"Students are blindfolded for a period of about one hour," she said. "It really demonstrates how much we take for granted – suddenly activities such as eating and socialising become difficult and exhausting. There is always at least one dinner guest who feels they can't cope and has to remove their blindfold."

Read more Medical News

› Verified 4 days ago

Entity NameThe General Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023049236
PECOS PAC ID: 6507803806
Enrollment ID: O20080313000351

News Archive

CDI, Promega enter collaboration for toxicity testing in drug discovery process

Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.

Researchers demonstrate important functional role of lincRNA in immune system

A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Interview highlights Kenya's first national health conference, examines role of women in building strong health systems

In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."

Students will temporarily lose their sight in an attempt to gain an understanding of what it could be like to have vision impairment

"Students are blindfolded for a period of about one hour," she said. "It really demonstrates how much we take for granted – suddenly activities such as eating and socialising become difficult and exhausting. There is always at least one dinner guest who feels they can't cope and has to remove their blindfold."

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael Tse-yin Lu is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Michael Tse-yin Lu, MD
55 Fruit St, Massachusetts General Hospital, Department Of Radiology,
Boston, MA 02114-2621

Ph: () -
Dr Michael Tse-yin Lu, MD
55 Fruit St, Massachusetts General Hospital, Department Of Radiology,
Boston, MA 02114-2621

Ph: (161) 724-9729

News Archive

CDI, Promega enter collaboration for toxicity testing in drug discovery process

Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.

Researchers demonstrate important functional role of lincRNA in immune system

A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.

Phase 2b clinical study initiated to evaluate GI safety of LT-NS001

Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal safety of its investigational drug LT-NS001 (naproxen etemesil). The study will compare the cumulative rate of gastric ulcers vs. Naprosyn after 12 weeks of treatment.

Interview highlights Kenya's first national health conference, examines role of women in building strong health systems

In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."

Students will temporarily lose their sight in an attempt to gain an understanding of what it could be like to have vision impairment

"Students are blindfolded for a period of about one hour," she said. "It really demonstrates how much we take for granted – suddenly activities such as eating and socialising become difficult and exhausting. There is always at least one dinner guest who feels they can't cope and has to remove their blindfold."

Read more News

› Verified 4 days ago


Radiology Doctors in Boston, MA

Jennifer Michelle Thomas, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 75 Francis St, Department Of Radiology, Boston, MA 02115
Phone: 617-732-6248    
Dr. Meghavi Mashar, MB BCHIR
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 330 Brookline Ave, Boston, MA 02215
Phone: 617-667-7000    
Rafeeque A Bhadelia, M.D
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 330 Brookline Ave, Bidmc Wcc90, Boston, MA 02215
Phone: 617-754-2058    Fax: 617-754-2004
Dr. Srinivasan Mukundan Jr., M.D.
Radiology
Medicare: Medicare Enrolled
Practice Location: 75 Francis St, Brigham And Women's Hospital, Boston, MA 02115
Phone: 617-732-7260    
Raymond W Liu, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fruit St, Grb 293, Boston, MA 02114
Phone: 917-923-2079    
Dr. Hillary R. Kelly, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Massachusetts General Hospital, 55 Fruit Street, Grb-273a, Boston, MA 02114
Phone: 617-726-8320    Fax: 617-724-3338
Dr. Tina Young Poussaint, MD
Radiology
Medicare: May Accept Medicare Assignments
Practice Location: 300 Longwood Ave, Boston, MA 02115
Phone: 617-355-6450    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.